Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Thyroid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 23,425Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 28, 2026
    Enforcement Report - Week of January 28, 2026

    28 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-28-2026-48857.pdf

    FDA
    28 Jan 2026
    Share Share
    Lirum Therapeutics debuts LX-101 results in Thyroid Eye Disease
    Lirum Therapeutics debuts LX-101 results in Thyroid Eye Disease

    17 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/17/3043688/0/en/Lirum-Therapeutics-Announces-Debut-of-LX-101-Results-in-Thyroid-Eye-Disease-Selected-for-Presentation-at-the-2025-NANOS-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Mar 2025
    Share Share
    Viridian Completes THRIVE-2 Enrollment For VRDN-001 In Chronic TED
    Viridian Completes THRIVE-2 Enrollment For VRDN-001 In Chronic TED

    25 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240725241981/en

    BUSINESSWIRE
    25 Jul 2024
    Share Share
    AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer
    AffyImmune Gets FDA RMAT Designation For AIC100 In Thyroid Cancer

    23 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240723305679/en

    BUSINESSWIRE
    23 Jul 2024
    Share Share
    Veracyte's Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis
    Veracyte's Afirma GRID Suggests Thyroid Tumor Molecular Testing Prognosis

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603031308/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Entera's Oral PTH Hypoparathyroidism Candidate EB612 Phase 1 Data
    Entera's Oral PTH Hypoparathyroidism Candidate EB612 Phase 1 Data

    03 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/03/2892199/0/en/Entera-Bio-Reports-Phase-1-Clinical-Data-of-First-in-Class-Oral-PTH-1-34-Peptide-Candidate-EB612-for-Patients-with-Hypoparathyroidism-at-ENDO-2024.html

    GLOBENEWSWIRE
    03 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.